文献速递主动脉外科

E-vita Open混合支架在复杂胸主动脉疾病中的长期经验

Long-term experience with the E-vita Open hybrid graft in complex thoracic aortic disease†.
PubMed 文献 · Eur J Cardiothorac Surg · 2017-01-01

本研究回顾了178例因急性或慢性I型主动脉夹层及复杂胸主动脉瘤接受E-vita Open混合支架手术的患者,随访长达10年。结果显示30天死亡率为10%,无支架近端内漏或移植物失败,但远端主动脉重构不良及再干预需求在慢性夹层中较高。

要点

  • E-vita Open混合支架长期耐久,无近端内漏或移植物失败。
  • 30天死亡率10%,急性夹层10%,慢性夹层7%,动脉瘤13%。
  • 远端主动脉负性重构在慢性夹层中达41%,需密切随访。

核心结论

  • E-vita Open混合支架长期性能持久,无近端内漏或移植物失败,可作为后续腔内或开放手术的理想锚定区。

研究设计与样本

  • 回顾性单中心研究,2005年2月至2015年3月连续178例患者,平均年龄59±11岁,其中急性夹层96例、慢性夹层43例、胸主动脉瘤39例。

主要发现

  • 总体30天死亡率为10%,急性夹层10%,慢性夹层7%,胸主动脉瘤13%。
  • 7年估计生存率急性夹层55%,慢性夹层74%,胸主动脉瘤73%。
  • 免于主动脉相关晚期死亡:总体94%,急性夹层91%,慢性夹层100%,胸主动脉瘤97%。
  • 支架远端正向或稳定重构:急性夹层92%,慢性夹层82%;动脉瘤完全隔绝88%。
  • 远端负性重构:急性夹层27%,慢性夹层41%,胸主动脉瘤22%。

关键数值与推荐

  • 单变量分析中,低左心室射血分数、外周动脉疾病、慢性阻塞性肺疾病和血流动力学严重受损为院内死亡危险因素。
  • 逻辑回归分析确定血流动力学受损和体外循环时间为显著危险因素。
  • 免于远端腔内干预:急性夹层96%,慢性夹层75%,胸主动脉瘤74%。
  • 免于胸腹手术:急性夹层97%,慢性夹层65%,胸主动脉瘤93%。

临床怎么用

  • E-vita Open混合支架可用于急诊和择期复杂胸主动脉疾病的单阶段治疗,长期耐久性良好。
  • 术后需长期随访远端主动脉,尤其慢性夹层患者负性重构和再干预风险较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The E-vita Open hybrid stent graft is intended to achieve one-stage treatment of the proximal and distal thoracic aorta down to the mid-thoracic level in cases of acute (AAD) or chronic (CAD) type I aortic dissection and complex thoracic aortic aneurysm (TAA). We report our long-term results up to 10-year experience. METHODS: From February 2005 until March 2015, 178 consecutive patients (mean age 59 ± 11 years) underwent surgery using the E-vita Open hybrid graft for AAD ( n = 96), CAD ( n = 43) or TAA ( n = 39). Pre-, intra- and postoperative variables, influential procedural improvements and follow-up data including aortic remodelling analyses are presented. RESULTS: Overall 30-day mortality was 10%, 10% for AAD, 7% for CAD and 13% for TAA. Univariable analysis identified low left ventricular ejection fraction, peripheral arterial disease, chronic obstructive pulmonary disease and severely compromised haemodynamics as risk factors for in-hospital death. Logistic regression analysis defined compromised haemodynamics and duration of cardiopulmonary bypass as significant. After 7 years, estimated survival was 55% for AAD, 74% for CAD and 73% for TAA patients. Freedom from aorta-related late death was 94%, 91% in AAD, 100% in CAD and 97% in TAA. Positive or stable aortic remodelling down to the stent graft end was achieved in 92% AAD, 82% in CAD and full aneurysmal exclusion in 88%. Further downstream, negative remodelling was observed in 27% of the AAD, 41% of the CAD and 22% of the TAA patients. Freedom from endovascular intervention downstream was 96% in AAD, 75% in CAD and 74% in TAA patients. Freedom from thoraco-abdominal surgery was 97%, 65% and 93%, respectively. CONCLUSIONS: The E-vita Open hybrid stent graft renders durable long-term performance without any proximal endoleakage or graft failure over time and represents the ideal landing or docking zone for either thoracic endovascular thoracic repair or thoraco-abdominal surgery, if required. No reinterventions were necessary down to the end of the stent graft, proving that the disease is overcome along the hybrid graft down to mid-thoracic level.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Jakob H, Dohle D, Benedik J, et al. Long-term experience with the E-vita Open hybrid graft in complex thoracic aortic disease†. Eur J Cardiothorac Surg. 2017. PMID: 28082472. doi:10.1093/ejcts/ezw340

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。